...
首页> 外文期刊>Journal of the American Academy of Dermatology >The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
【24h】

The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.

机译:在临床发现,组织学和免疫组织化学的背景下,分子诊断在原发性皮肤B细胞淋巴瘤中的价值。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Primary cutaneous B-cell lymphoma (PCBCL) is classified into 3 major subtypes: primary cutaneous follicle center lymphoma (PCFCL); primary cutaneous marginal zone B-cell lymphoma (PCMZL); and primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL, LT). Diagnosis of PCBCL is mainly based on clinical and (immuno)-histochemical grounds. OBJECTIVE: We investigated the diagnostic value of the BIOMED-2 Concerted Action BMH4 CT98-3936 protocol in PCBCL. METHODS: We analyzed with the BIOMED-2 Concerted Action BMH4 CT98-3936 protocol skin specimens from patients with well-defined clinical and (immuno)-histologic PCBCL (n = 18) in comparison with benign lymphocytic infiltrates (n = 9). For molecular staging we also investigated 13 extracutaneous samples from 6 patients with PCLBCL, LT. Each sample was investigated at least twice. RESULTS: Monoclonality was detected in all of 5 PCFCL; 5 of 6 PCMZL; all of 6 PCLBCL, LT; and 2 of 9 benign lymphocytic infiltrates. In 5 of 6 patients with PCLBCL, LT, a clone corresponding to the clone detected in the skin was detected in 3 of 5 bone-marrow, 4 of 5 blood, and 1 of 3 lymph node specimens. DNA amplification using tubes A and B of IgH was not possible in PCFCL/PCMZL, benign lymphocytic infiltrates, and extracutaneous specimens of PCLBCL, LT, even after repeated analysis up to 11 times. Pseudomonoclonality was identified by repeated analyses in one case of PCMZL and in one case of benign lymphocytic infiltrate. LIMITATIONS: A multicentric, randomized, blinded study is necessary to confirm our results. CONCLUSION: Molecular diagnosis supports the clinical and (immuno)-histologic diagnosis in PCBCL. In PCLBCL, LT, molecular staging may be useful. Tubes C through E of IgH and Igkappa analyses seem to be superior to tubes A and B of IgH. Each sample should be analyzed at least twice to assess the possibility of pseudomonoclonality.
机译:背景:原发性皮肤B细胞淋巴瘤(PCBCL)分为三种主要亚型:原发性皮肤卵泡中心淋巴瘤(PCFCL);原发性皮肤滤泡中心性淋巴瘤(PCFCL)。原发性皮肤边缘区B细胞淋巴瘤(PCMZL);和原发性皮肤弥漫性大B细胞淋巴瘤,腿型(PCLBCL,LT)。 PCBCL的诊断主要基于临床和(免疫)组织化学依据。目的:我们研究了BIOMED-2协同行动BMH4 CT98-3936协议在PCBCL中的诊断价值。方法:我们使用BIOMED-2协同行动BMH4 CT98-3936协议分析了具有明确临床和(免疫)组织学PCBCL(n = 18)患者的皮肤样本,并与良性淋巴细胞浸润(n = 9)进行了比较。对于分子分期,我们还研究了6例PCLBCL,LT患者的13个皮外样本。每个样品至少要检查两次。结果:在5个PCFCL中均检测到了克隆性; 6个PCMZL中的5个;全部6个PCLBCL,LT;和9个良性淋巴细胞浸润中的2个。在6例PCLBCL,LT患者中,有5例在5例骨髓中有3例,5例血液中有4例以及3例淋巴结样本中有1例与皮肤中检测到的克隆相对应。在PCFCL / PCMZL,良性淋巴细胞浸润以及PCLBCL,LT的皮外标本中,即使经过多达11次的重复分析,也无法使用IgH的A和B管进行DNA扩增。通过对1例PCMZL和1例良性淋巴细胞浸润进行反复分析,确定了假单胞菌性。局限性:需要进行多中心,随机,盲法研究以确认我们的结果。结论:分子诊断支持PCBCL的临床和(免疫)组织学诊断。在PCLBCL,LT中,分子分期可能有用。 IgH和Igkappa分析的试管C至E似乎优于IgH的试管A和B。每个样品应至少分析两次,以评估假单胞菌的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号